Medicine shortages
Our work to highlight how medicine shortages affect patient care, the pressures on pharmacy teams, and recommendations to inform action.


From our President Tase Oputu
On 15 April 1841, a dedicated group of London chemists and druggists came together to form a professional body. Today, 185 years later, I am immensely proud to welcome you…
News
The latest news and updates from Royal College of Pharmacy
-
Royal College of Pharmacy walks with APTUK at London Pride 2026
The Royal College of Pharmacy (RCPharm) joined members, colleagues and partners at London Pride 2026 on 4 July, showing support for the LGBTQIA+ community and celebrating equality, diversity and inclusion. We walked alongside members and colleagues from APTUK, with Boots on Oxford Street kindly hosting the group before the parade. Tase Oputu, President of RCPharm, who attended the parade, said: "It was a privilege to join colleagues, members and allies at London Pride to show support for the LGBTQIA+ community. “Pride is a celebration of diversity, visibility and inclusion, and reflects the values we strive to uphold as a profession. Seeing so many people come together in support of equality was both inspiring and a powerful reminder of the importance of creating a profession where everyone feels respected, valued and able to thrive." Source: RCPharm Find our more about our inclusion and diversity work. Read more news stories.
-
Royal College of Pharmacy and partners sign Concordat on pharmacy professional leadership
The Royal College of Pharmacy (RCPharm) is one of seven pharmacy professional leadership bodies and specialist professional groups, along with independent expert members, that comprise the UK Pharmacy Professional Leadership Advisory Board. Since April 2024, the Board has been working to co-create a stronger, more inclusive, effective and sustainable pharmacy professional leadership model for the future. The Board has today (25 June) published a Concordat, which builds on its statement of February 2026 and sets out a shared commitment to collaboration, transparency and engagement to establish the Royal College as the professional leadership home for pharmacy. Tase Oputu, president of the Royal College of Pharmacy, said: “This Concordat is a significant moment for pharmacy professional leadership, and we commend the Board, under Sir Hugh’s leadership, for their ambition and shared commitment to working collaboratively toward a unified future that benefits professionals and the public. The Concordat hands the baton to member organisations to make that unified future a reality, and I particularly welcome the clear articulation of UKPPLAB members’ shared pledge to co-creating an ambitious and inclusive royal college as a wider home for pharmacy. “To create a unified, collaborative future for pharmacy professional leadership, we need an ambitious long-term strategy for the Royal College, and we are committed to ensuring our members, and the wider pharmacy community, can play their part in developing this strategy and help shape the future direction of the College. “The Concordat sets out a vision and an ambitious timeline for an inclusive future in which pharmacy technicians are part of the Royal College, a change which would require a positive Special Resolution Vote by College members. Ahead of launching such a vote, we will need to be clear with our members and pharmacy technicians how we would protect distinct professional voices and create clear arrangements for equity and governance. “Together, we can build the future that pharmacy professionals and patients deserve.” The College will shortly announce a programme of engagement starting in autumn 2026. Read the Concordat Read more news stories.
-
Royal College of Pharmacy welcomes government action on palliative care
The Royal College of Pharmacy has welcomed the government’s acceptance of the Health and Social Care Committee’s recommendations to improve access to palliative and end-of-life care, including plans for a 24/7 care framework and a single patient record. Amandeep Doll, director for England at the Royal College of Pharmacy, said: “We welcome the government's acceptance of recommendations to improve access to palliative and end-of-life care. “Timely access to medicines and support from pharmacy teams must be a core part of any successful model of palliative care. Pharmacists help people manage symptoms, access urgent medicines and receive care in the setting of their choice. “We are also pleased to see support for a single patient record. Better sharing of patient information across healthcare services would improve communication, support safer clinical decisions and help deliver more joined-up care. “Our own position on palliative care aligns with many of the recommendations. Our Daffodil Standards provide a quality improvement framework, which helps the whole pharmacy team to improve the care provided to patients needing palliative and end of life care. “As the NHS seeks to deliver more care closer to home through the 10-year Health Plan, pharmacists must be fully integrated into multidisciplinary teams so patients and their families can access timely, coordinated support when they most need it.” The College will continue working with partners to ensure pharmacy is central to delivering high-quality, accessible palliative care services. Read more news stories.


Have any questions or comments on the new Royal College website?
Please visit our support page or email [email protected]

We are the Royal College of Pharmacy, the professional leadership body for pharmacists and pharmaceutical scientists. We exist to advance the safe and effective use of medicines, drive excellence in patient care and support pharmacists to deliver the highest standards of practice.
As the third largest workforce in healthcare, pharmacy plays a vital role in the health system, and as experts in medicines, pharmacists and their teams are central to patient care and public health. Our mission is to put pharmacy at the forefront of patient care, advancing the safe and effective use of medicines to the benefit of patients and the public.




